OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nirmatrelvir/ritonavir for patients with SARS-CoV-2 infection and impaired kidney function during the Omicron surge
Jiayi Yan, Hong Cai, Jieying Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Jiayi Yan, Hong Cai, Jieying Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Showing 8 citing articles:
Association of nirmatrelvir–ritonavir with post-acute sequelae and mortality in patients admitted to hospital with COVID-19: a retrospective cohort study
Huwen Wang, Yuchen Wei, C.T. Hung, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 10, pp. 1130-1140
Open Access | Times Cited: 13
Huwen Wang, Yuchen Wei, C.T. Hung, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 10, pp. 1130-1140
Open Access | Times Cited: 13
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19
Stefanie Reis, Maria‐Inti Metzendorf, Rebecca Kuehn, et al.
Cochrane library (2023) Vol. 2023, Iss. 11
Open Access | Times Cited: 22
Stefanie Reis, Maria‐Inti Metzendorf, Rebecca Kuehn, et al.
Cochrane library (2023) Vol. 2023, Iss. 11
Open Access | Times Cited: 22
Ritonavir: 25 Years’ Experience of Concomitant Medication Management. A Narrative Review
Romina Quercia, Giovanni Di Perri, C. Pein, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 5, pp. 1005-1017
Open Access | Times Cited: 5
Romina Quercia, Giovanni Di Perri, C. Pein, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 5, pp. 1005-1017
Open Access | Times Cited: 5
Efficacy and safety of antiviral therapies for the treatment of persistent COVID-19 in immunocompromised patients since the Omicron surge: a systematic review
Caroline Hirsch, Nina Kreuzberger, Nicole Skoetz, et al.
Journal of Antimicrobial Chemotherapy (2025)
Open Access
Caroline Hirsch, Nina Kreuzberger, Nicole Skoetz, et al.
Journal of Antimicrobial Chemotherapy (2025)
Open Access
Effectiveness of nirmatrelvir‐ritonavir on severe outcomes of COVID‐19 in the era of vaccination and Omicron: An updated meta‐analysis
Sien Ombelet, Diego Castanares‐Zapatero, Fabian Desimpel, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 2
Open Access | Times Cited: 2
Sien Ombelet, Diego Castanares‐Zapatero, Fabian Desimpel, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 2
Open Access | Times Cited: 2
Oral Agents and SARS-CoV-2 Vaccine Effectiveness against Severe COVID-19 Omicron Events in Patients Requiring Maintenance Dialysis
Harold J. Manley, Nien Chen Li, Caroline M. Hsu, et al.
Kidney360 (2024) Vol. 5, Iss. 3, pp. 445-450
Open Access
Harold J. Manley, Nien Chen Li, Caroline M. Hsu, et al.
Kidney360 (2024) Vol. 5, Iss. 3, pp. 445-450
Open Access
Population pharmacokinetics of nirmatrelvir/ritonavir in critically ill Chinese COVID-19 patients and recommendations for medication use: a two-center retrospective study
Junjun Xu, Jinmeng Li, Meng Chen, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 11, pp. 1071-1079
Closed Access
Junjun Xu, Jinmeng Li, Meng Chen, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 11, pp. 1071-1079
Closed Access
